Pallavi Manvar-Singh, MD
Zucker School of Medicine at Hofstra/Northwell Health
Jericho, New York
Peter Schneider, MD
Vascular Surgeon
University of California San Francisco
San Francisco, California
Summary:Management of carotid occlusive is currently in a period of transition after more than 10-year period of stability based upon previous randomized trials. Most vascular surgeons have many questions about the data, the plan of CMS to change the NCD (finalized on October 11, 2023), and whether stent-based therapies will replace CEA.
Speaker: Caitlin W. Hicks, MD, MS (she/her/hers) – Johns Hopkins University
Speaker: Warren J. Gasper, MD – Division of Vascular & Endovascular Surgery, University of California San Francisco
Speaker: Mark F. Conrad, MD, MS – Steward Health
Speaker: Sonya S. Noor, MD – Gates Vascular Institute
Speaker: Sean P. Lyden, MD – Department of Vascular Surgery, Heart Vascular and Thoracic Institute, Cleveland Clinic
Speaker: Gregg S. Landis, MD – Zucker School of Medicine at Hofstra/Northwell
Speaker: Mazin I. Foteh, MD (he/him/his) – Cardiothoracic and Vascular Surgeons
Speaker: Jeffrey Jim, MD – Minneapolis Heart Institute at Abbott Northwestern Hospital